Pharmacist Intervention Lowers HgbA1c in Diabetic Patients Regardless of HIV Status.
Noelle E NelsonMachelle WilsonJeffrey FineRebecca M HluhanichPublished in: Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia (2021)
The study demonstrated clinically important HgbA1c reductions without increasing the medication burden in most patients. There was no significant difference in glycemic management between HIV-positive and HIV-negative patients.
Keyphrases
- hiv positive
- antiretroviral therapy
- end stage renal disease
- men who have sex with men
- ejection fraction
- newly diagnosed
- human immunodeficiency virus
- chronic kidney disease
- hiv infected
- randomized controlled trial
- south africa
- type diabetes
- hepatitis c virus
- prognostic factors
- hiv testing
- peritoneal dialysis
- metabolic syndrome
- patient reported outcomes
- adverse drug
- patient reported